During the projection period, it is anticipated that the rising prevalence of numerous infectious disorders, such as COVID-19, will fuel market expansion. For instance, as of February 8, 2022, the World Health Organisation Coronavirus (COVID-19) dashboard reported over 396,558,014 cases and 5,745,032 deaths attributed to the coronavirus.
The market for Antibody Cocktails was estimated at US$ 2,113.5 million in 2021, and from 2021 and 2028, it is anticipated to grow at a CAGR of 10.9%.
Prominent Companies in the Antibody Cocktails Industry:
1. Cipla Inc.: Cipla Ltd is a drug manufacturing company that focuses on a variety of pharmaceutical products. The company's product portfolio spans complex generics as well as drugs in the anti-retroviral, CNS, urology, cardiology, anti-infective, respiratory, and various other key therapeutic segments. Founded in 1935. Headquarters at Mumbai, Maharashtra. Latest acquisition is Endura.
2. Hoffmann-La Roche Ltd: Tasmar's rights to production, marketing, and distribution in the United States and a few other non-European Union areas. Parkinson's illness is managed with the medication tasmar. Roche plans to purchase the TIB Molbiol Group, with a closing anticipated for the fourth quarter of 2021.
3. Regeneron Pharmaceuticals Inc.: Established in 1988, with headquarters in Tarrytown, New York, Regeneron Pharmaceuticals finds, creates, and sells medicines to treat inflammation, cancer, cardiovascular disease, and eye disorders.
4. Zydus Cadila,: Zydus Lifesciences Ltd is a specialty and generic drug manufacturing company. Founded in 1952. Headquarters at Ahmedabad.
5. Immunome Inc.: A biopharmaceutical business is mmunome Inc. It is actively involved in discovering and developing first-in-class antibody therapies intended to transform the way diseases are currently treated using a proprietary human memory B cell platform. Established in 2006. American headquarters at Exton. Strategic Collaboration to Identify Multiple Novel Oncology Targets Announced by AbbVie and Immunome.
6. Celltrion Healthcare Co.,Ltd.: Celltrion Healthcare Co Ltd uses a vast global network that spans more than 120 different countries, including developed and developing markets, to promote, sell, and deliver biological and biosimilar medicines created by the firm. Established in 1999. Headquarters in South Korea's Incheon. Takeda Pharmaceutical Company Limited's Primary Care (PC) Product Assets for Asia Pacific Markets were successfully acquired by Celltrion.
7. Eli Lilly and Company: Eli Lilly and Company: Eli Lilly is a pharmaceutical company that specialises in immunology, oncology, neuroscience, and endocrinology. Verzenio for cancer, Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes, Taltz, and Olumiant for immunology are some of Lilly's most important pharmaceuticals. Founded in 1975. United States city of Indianapolis. The purchase expands upon a prior co-promotion agreement, wherein Sanofi lent its commercialization clout.
More Insights:
*Definition: In these studies, a cocktail of two powerful, complementary, antibodies that neutralise viruses called REGN-COV2 was used.
